Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 4

Status

Unknown 3Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 4Lymphoid 3Other hematologic neoplasm 2Thoracic 1NET 1Myeloid 1Endocrine 1

Conditions

Multiple Myeloma 4Lymphoma 2Lymphoma, Non-Hodgkin 1Leukemia 1Histiocytosis, Sinus 1Erdheim-Chester Disease 1

Interventions

Dexamethasone 871Bortezomib 457Lenalidomide 456Cyclophosphamide 365Melphalan 272Calcium Dobesilate 263daratumumab 234pomalidomide 208carfilzomib 182fludarabine phosphate 140fludarabine 136Thalidomide 125Peripheral Blood Stem Cell Transplantation 119Filgrastim 114ixazomib 93Mycophenolic Acid 90Granulocyte Colony-Stimulating Factor 89Whole-Body Irradiation 87Busulfan 87dexamethasone acetate 86Tacrolimus 78dexamethasone 21-phosphate 74isatuximab 69Cyclosporine 68auricularum 67Prednisone 65elotuzumab 58belantamab mafodotin 57Antilymphocyte Serum 56Etoposide 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × 68Ga-pentixafor × Plasma cell × Clear all
NCT05093335 2026-02-05

In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET

Memorial Sloan Kettering Cancer Center

Phase EARLY_PHASE1 Recruiting
30 enrolled
LymphoidMyeloidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Histiocytosis, Sinus, Erdheim-Chester Disease

NCT04504526 2023-09-15

Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases

First Affiliated Hospital of Fujian Medical University

Phase EARLY_PHASE1 Unknown
50 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma

NCT05364177 2022-05-06

68Ga-pentixather and 68Ga-pentixafor PET/CT in Multiple Myeloma

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Unknown
100 enrolled
Plasma cell

Multiple Myeloma

NCT03436342 2019-12-27

Chemokine Receptor CXCR4-targeting Molecular Imaging for Metabolic Characterization of Multiple Myeloma and Lymphoma

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Unknown
100 enrolled
LymphoidPlasma cell

Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡